ISIS Pharma, BAD Name, Hot Pipeline – Major ramp to new highs

By |2017-04-25T18:03:50+00:00December 15th, 2014|Uncategorized|

Shares of Isis Pharmaceuticals closed Friday at an all-time high of $62.32. Isis edged up 45 cents for the day, nosing out the previous record of $61.87, reached Thursday. The Carlsbad biotech is up 63 percent from a year ago, and more than six times its price on Dec. 12, 2012, when it closed at [...]

Read More
Comments Off on ISIS Pharma, BAD Name, Hot Pipeline – Major ramp to new highs

FDA Acceptance of Smaller Clinical Trials Offers Upside to Biotech Stocks:

By |2014-12-05T15:36:09+00:00December 5th, 2014|Pharma News|

The biotech index is more than a triple bagger ramp since 2010. As a student of the market for over 20 years, with clinical research funding dropping, is there a top anywhere in sight? SZIMM Exclusive Interview with David Nierengarten, Ph.D., an Analyst at Wedbush Securities Covering the Biotechnology and Biopharmaceuticals Sector TWST: What's the FDA [...]

Read More
Comments Off on FDA Acceptance of Smaller Clinical Trials Offers Upside to Biotech Stocks:
Go to Top